Literature DB >> 2647865

Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.

T J Barrett1, M E Potter, I K Wachsmuth.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2647865     DOI： 10.1093/infdis/159.4.774

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  15 in total

1.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.

Authors:  M Bielaszewska; I Clarke; M A Karmali; M Petric
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

3.  Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II.

Authors:  E A Wadolkowski; L M Sung; J A Burris; J E Samuel; A D O'Brien
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies.

Authors:  D Karpman; A Håkansson; M T Perez; C Isaksson; E Carlemalm; A Caprioli; C Svanborg
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

6.  The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.

Authors:  Tania N Petruzziello-Pellegrini; Darren A Yuen; Andrea V Page; Sajedabanu Patel; Anna M Soltyk; Charles C Matouk; Dennis K Wong; Paul J Turgeon; Jason E Fish; J J David Ho; Brent M Steer; Vahid Khajoee; Jayesh Tigdi; Warren L Lee; David G Motto; Andrew Advani; Richard E Gilbert; S Ananth Karumanchi; Lisa A Robinson; Phillip I Tarr; W Conrad Liles; James L Brunton; Philip A Marsden
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

7.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

8.  Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances.

Authors:  H Tashiro; S Miura; I Kurose; D Fukumura; H Suzuki; M Suematsu; M Yoshioka; M Tsuchiya; A Kai; Y Kudoh
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

9.  A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.

Authors:  Y Harel; M Silva; B Giroir; A Weinberg; T B Cleary; B Beutler
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

10.  Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.

Authors:  V L Tesh; B Ramegowda; J E Samuel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.